| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 32 |
| 1 | PANTOPRAZOLE | 17 |
| 2 | FUROSEMIDE | 13 |
| 3 | ALLOPURINOL | 12 |
| 4 | TORSEMIDE | 12 |
| 5 | CANDESARTAN CILEXETIL | 11 |
| 6 | OMEPRAZOLE | 11 |
| 7 | OMEPRAZOLE MAGNESIUM | 11 |
| 8 | SPIRONOLACTONE | 11 |
| 9 | DEXAMETHASONE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEPIVACAINE HYDROCHLORIDE | 9 | 0.0078 |
| 1 | PANTHENOL | 1 | 0.0034 |
| 2 | VERAPAMIL HYDROCHLORIDE | 9 | 0.0021 |
| 3 | PIROXICAM | 9 | 0.0014 |
| 4 | PSYLLIUM HUSK | 1 | 0.0007 |
| 5 | CANDESARTAN CILEXETIL | 11 | 0.0004 |
| 6 | NEOMYCIN OINTMENT | 1 | 0.0004 |
| 7 | RITUXIMAB-ABBS | 2 | 0.0004 |
| 8 | TORSEMIDE | 12 | 0.0004 |
| 9 | AMIODARONE HYDROCHLORIDE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | General Anesthetic [EPC] | 9 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |
| 4 | Integrin Receptor Antagonist [EPC] | 10 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 8 | 0.0001 |
| 6 | Aminosalicylate [EPC] | 8 | 0.0001 |
| 7 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 8 | Aldosterone Antagonist [EPC] | 11 | 0.0001 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 12 | 0.0001 |